ReViral Funding: $154M Raised, IPO

ReViral funding overview

ReViral is based in UK. ReViral has raised $154M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO. Investors on record include New Leaf Venture Partners, Novo Ventures, CR-CP Life Science Fund, Andera Partners, Brace Pharma Capital, Green Sands Equity and 4 others. 10 distinct backers are named across the disclosed rounds.

ReViral at a glance

Total raised: $154M
Latest round: IPO
Headquarters: UK
Notable investors: New Leaf Venture Partners, Novo Ventures, CR-CP Life Science Fund, Andera Partners, Brace Pharma Capital, Green Sands Equity, Novo Holdings, OrbiMed Advisors

Frequently asked about ReViral funding

How much has ReViral raised?: ReViral has raised $154M in total disclosed funding across the rounds on record.
Who has invested in ReViral?: New Leaf Venture Partners, Novo Ventures, CR-CP Life Science Fund, Andera Partners, Brace Pharma Capital, Green Sands Equity are named among the investors backing ReViral.
What was the latest ReViral funding round?: The most recent disclosed round is an IPO.
Where is ReViral based?: ReViral is based in UK.

Totals shown for ReViral aggregate every disclosed round on file. To see how that compares, browse the companies in UK and the investors behind them below.

ReViral Funding: $154M Raised, IPO

ReViral funding overview

ReViral at a glance

Frequently asked about ReViral funding

Companies related to ReViral (32)

Browse related funding lists (5)